CD4 and cancer: By using single-cell RNA-sequencing (RNA-seq) technology, it has become clear that several CD4+ T helper cell subtypes infiltrate into the tumor microenvironment (TME); these are cytolytic CD4+ T cells that express high levels of granzymes and perforin and may contribute to the anti-cancer response [77].